Chidamide (Tucidinostat)
Lymphoma (and other cancers)
Approved/MarketedCommercial; Included in NRDL
Key Facts
Indication
Lymphoma (and other cancers)
Phase
Approved/Marketed
Status
Commercial; Included in NRDL
Company
About Chipscreen Biosciences
A Chinese biotech pioneer developing original small molecule drugs for oncology and metabolic diseases using chemical genomics and AI platforms.
View full company profile